Chemoembolisation offers survival benefit for people with liver cancer
People with liver cancer that cannot be treated with surgical resection or transplantation could have an increased two-year survival if they are given chemoembolisation-a procedure in which blood supply to the tumour combined with the effect of chemotherapy inhibits cancer growth.
There is no standard treatment for liver cancer when surgery, transplantation, or percutaneous treatment is not possible, which applies to around three-quarters of all liver cancer cases. Arterial embolisation-the restriction of blood supply to the tumour-is widely used, but there is uncertainty whether it has a survival benefit.
Jordi Bruix and Josep Llovet from Hospital Clinic, Barcelona, Spain, lead a multicenter randomised trial among 112 cirrhotic patients with unresectable liver cancer to assess the survival benefits of arterial embolisation (use of gelatin sponge to block blood flow to the tumour) or chemoembolisation (gelatin sponge plus the chemotherapeutic drug doxorubicin) compared with conservative treatment.
The trial was stopped when it became apparent that chemoembolisation had a substantial survival benefit compared with conservative treatment. 25 of 37 patients assigned embolisation, 21 of 40 assigned chemoembolisation, and 25 of 35 assigned conservative treatment died. Survival probabilities at 1 year and 2 years were 75% and 50% for embolisation; 82% and 63% for chemoembolisation, and 63% and 27% for conservative treatment.
Jordi Bruix comments: “While we wait for confirmatory studies and from now on, chemoembolisation should become the standard approach for a selected group of candidates (unresectable intermediate hepatocellular carcinoma and preserved liver function).”
All latest news from the category: Health and Medicine
This subject area encompasses research and studies in the field of human medicine.
Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.
Researchers use breakthrough method to answer key question about electron states
Scientists are working hard to engineer the properties of nanostructures, such as atoms and molecules, to realize efficient logic devices that can operate at the fundamental scale of matter –…
Scientists develop artificial intelligence method to predict anti-cancer immunity
Machine learning algorithms are shedding light on neoantigen T cell-receptor pairs. Researchers and data scientists at UT Southwestern Medical Center and MD Anderson Cancer Center have developed an artificial intelligence…